BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37503578)

  • 1. Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials.
    Scharpenberg M; Brannath W
    Stat Methods Med Res; 2023 Sep; 32(9):1784-1798. PubMed ID: 37503578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-stage, three-arm, adaptive test strategies for non-inferiority trials with an unstable reference.
    Brannath W; Scharpenberg M; Schmidt S
    Stat Med; 2022 Nov; 41(25):5033-5045. PubMed ID: 35979723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous confidence interval for assessing non-inferiority with assay sensitivity in a three-arm trial with binary endpoints.
    Tang N; Yu B
    Pharm Stat; 2020 Sep; 19(5):518-531. PubMed ID: 32112669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of multiple testing procedures for the gold standard non-inferiority trial.
    Röhmel J; Pigeot I
    J Biopharm Stat; 2010 Sep; 20(5):911-26. PubMed ID: 20721781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing of non-inferiority and superiority for three-arm clinical studies with multiple experimental treatments.
    Zhong J; Wen MJ; Kwong KS; Cheung SH
    Stat Methods Med Res; 2018 Jun; 27(6):1751-1765. PubMed ID: 27647816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A studentized permutation test for three-arm trials in the 'gold standard' design.
    Mütze T; Konietschke F; Munk A; Friede T
    Stat Med; 2017 Mar; 36(6):883-898. PubMed ID: 27859506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A framework for testing non-inferiority in a three-arm, sequential, multiple assignment randomized trial.
    Paul E; Chakraborty B; Sikorskii A; Ghosh S
    Stat Methods Med Res; 2024 Apr; 33(4):611-633. PubMed ID: 38400576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials.
    Meis J; Pilz M; Herrmann C; Bokelmann B; Rauch G; Kieser M
    Stat Med; 2023 Feb; 42(4):536-558. PubMed ID: 36577519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conducting the non-inferiority test for the means with unknown coefficient of variation in a three-arm trial.
    Lee MC; Wu WY; Lu HY; Hsieh HN; Wu WH
    BMC Med Res Methodol; 2023 Aug; 23(1):183. PubMed ID: 37568109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints.
    Tang N; Yu B
    J Biopharm Stat; 2022 Sep; 32(5):768-788. PubMed ID: 35213275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and analysis of non-inferiority mortality trials in oncology.
    Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
    Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some essential considerations in the design and conduct of non-inferiority trials.
    Fleming TR; Odem-Davis K; Rothmann MD; Li Shen Y
    Clin Trials; 2011 Aug; 8(4):432-9. PubMed ID: 21835862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Designs for Non-inferiority Trials with Multiple Experimental Treatments.
    Xu W; Hu F; Cheung SH
    Stat Methods Med Res; 2018 Nov; 27(11):3255-3270. PubMed ID: 29298617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some practical considerations in three-arm non-inferiority trial design.
    Zhou M; Kundu S
    Pharm Stat; 2016 Nov; 15(6):550-559. PubMed ID: 27681603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.